Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

08 Nov, 2017, 09:16 GMT Novartis Launches Joint Working Project with the Royal Marsden Partners Cancer Vanguard to Improve Quality of Care and Increase Satisfaction Among Cancer Patients

- First pilot of a new cancer care model which leverages the role of the pharmacist by the Vanguard New Models of Care Programme -...


08 Nov, 2017, 08:50 GMT Cantargia Publishes Interim Report for Third Quarter of 2017

Cantargia AB's ("Cantargia") interim report for the third quarter of 2017 is now available on the company's web page...


08 Nov, 2017, 08:07 GMT Nordic Nanovector: Protocol Amendment Filed in the UK to Enable Initiation of Phase 2 PARADIGME

Nordic Nanovector ASA (OSE: NANO) notes that information relating to an application for a Protocol Amendment to the LYMRIT 37-01 study, for the...


07 Nov, 2017, 13:17 GMT Results From Alligator Bioscience's Clinical Phase I Study Support Further Clinical Development of ADC-1013

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


07 Nov, 2017, 09:00 GMT Global Experts Call for Action on Vaccination Apathy, and More Protection for Older Adults Against Infectious Diseases

- 'Vaccination apathy' is a key barrier to protecting the community against infectious disease, according to global health experts...


07 Nov, 2017, 09:00 GMT MyMeds&Me Appoints Experienced Healthtech and Pharma Entrepreneur as a Non-Executive Director

Appointment of Tim Davis will help the company enhance its Reportum® service and drive its commercial growth MyMeds&Me, the leading SaaS...


07 Nov, 2017, 09:00 GMT Merck's Consumer Health Leads Debate on Preparing Gen Z for 100 Healthy Years

- New whitepaper from Consumer Health business shines light on preparing the young generation for living 100 healthy years -...


06 Nov, 2017, 16:00 GMT New GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management

Findings from a new multi-country GSK survey, released today to coincide with the 2017 American College of Rheumatology/Association for...


06 Nov, 2017, 13:02 GMT Natera Selected for Circulating Tumor DNA Study in Colorectal Cancer

Second Study with Denmark's Aarhus University to Leverage Signatera™ (RUO) Personalized ctDNA Technology Natera, Inc., (NASDAQ: NTRA), a...


06 Nov, 2017, 08:45 GMT Switching to Tresiba® is Highly Cost-effective and Cost-saving in a Real-world Setting

Poster Presentation PDB27 A new analysis of real-world data has shown that switching to Tresiba® (insulin degludec) is highly cost-effective and...


06 Nov, 2017, 08:00 GMT Debiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)

The clinical trial is in collaboration with the Merck-Pfizer Alliance Debiopharm International SA (Debiopharm - http://www.debiopharm.com),...


06 Nov, 2017, 07:30 GMT Advicenne Announces Positive 6-Month Extension Study Data from Pivotal Phase III Study of ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA)

- Data presented at the American Society of Nephrology (ASN) meeting in New Orleans - Positive data will form basis for application seeking...


06 Nov, 2017, 06:00 GMT NousCom Raises €42 Million Series B Financing

NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platform, today announced the completion of a €42...


03 Nov, 2017, 12:30 GMT Jazz Pharmaceuticals Submits Vyxeos™ Marketing Authorization Application to European Medicines Agency for Treatment of Certain Types of High-Risk Acute Myeloid Leukemia

Vyxeos granted accelerated assessment review status from European Medicines Agency's Committee for Medicinal Products for Human Use Jazz...


02 Nov, 2017, 16:30 GMT Ascensia Diabetes Care Adds Further Experts to Judging Panel for Challenge and Expands Competition Into More Regions

Today, during the Diabetes Technology Meeting in Bethesda, MD, USA, Ascensia Diabetes Care announced two new judges that have been added to the...


02 Nov, 2017, 10:21 GMT Betagenon/Baltic Bio Announces Positive Results From a 28-day Phase IIa Trial of the First-in-class AMPK Activator O304 in Type 2 Diabetics

O304 reduces significantly fasting plasma glucose (FPG) in type 2 diabetics The main study results are not yet finalized. Review of the initial...


01 Nov, 2017, 18:10 GMT Late-Breaking REDUCE Trial Data Demonstrate Non-inferiority of 3 vs 12 Months Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Treated With the COMBO[TM] Stent

One-year results from the REDUCE trial reported at TCT 2017 OrbusNeich has reported results from the REDUCE trial today in the Late-Breaking...


01 Nov, 2017, 13:33 GMT Nordic Nanovector: Updated Results From Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH in December

Nordic Nanovector ASA (OSE: NANO) announces that updated results from its ongoing LYMRIT 37-01 Phase 1/2 clinical study of Betalutin®...


01 Nov, 2017, 12:03 GMT Natera Chosen for Longitudinal Circulating Tumor DNA Study in Breast Cancer

Collaboration with Imperial College London and University of Leicester to Leverage Signatera™ (RUO) Personalized ctDNA Technology Natera,...


01 Nov, 2017, 08:30 GMT Meta-Analysis Using Real-World Data Evaluates Safety Profile of Entyvio® (vedolizumab) in Patients with Moderate to Severe Ulcerative Colitis or Crohn's Disease

New meta-analysis provides a comprehensive view of real-world data and furthers understanding of Entyvio as an important treatment option...


01 Nov, 2017, 08:00 GMT CALCIVIS Announces Positive Results from PMA Clinical Study Evaluating its Unique CALCIVIS® Imaging System

CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces positive...


31 Oct, 2017, 16:16 GMT E.U. Funded Research Consortium "LipiDiDiet" Finds a way to Impact Alzheimer's Disease Before it's too Late: Data Published in The Lancet Neurology

Full results from the European LipiDiDiet clinical trial were published online today in The Lancet...


31 Oct, 2017, 08:00 GMT Atlantis Healthcare Issues White Paper on Enhancing Therapeutic Alliance

Atlantis Healthcare Ltd., the global leader in patient self-management and behavior change programs, today releases its latest White Paper...


31 Oct, 2017, 04:35 GMT Astute Medical Highlights Clinical Presentations And Activities At Kidney Week 2017

Astute Medical, Inc., developer of biomarkers for better healthcare, today previewed several presentations taking place in conjunction with the...


31 Oct, 2017, 04:00 GMT Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study...